Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14770319 | 0.99 | NPSR1 (0.38) | NPSR1EPHX2MEN1KMT2AL3MBTL1 | |
| SCHEMBL14760484 | 0.90 | NPSR1 (0.36) | NPSR1EPHX2MEN1KMT2AL3MBTL1 | |
| SCHEMBL14760564 | 0.88 | NPSR1 (0.37) | NPSR1 | |
| SCHEMBL14770349 | 0.87 | NPSR1 (0.38) | NPSR1MEN1KMT2AL3MBTL1 | |
| SCHEMBL24268504 | 0.86 | NPSR1 (0.41) | NPSR1MEN1KMT2AL3MBTL1 | |
| SCHEMBL14770325 | 0.84 | LMNA (0.35) | NPSR1EPHX2MEN1KMT2AL3MBTL1 | |
| SCHEMBL12333914 | 0.84 | NPSR1 (0.44) | NPSR1EPHX2MEN1KMT2AL3MBTL1 | |
| SCHEMBL14760465 | 0.83 | NPSR1 (0.38) | NPSR1MEN1KMT2AL3MBTL1 | |
| SCHEMBL14760515 | 0.82 | EPHX2 (0.34) | NPSR1EPHX2MEN1KMT2AL3MBTL1 | |
| SCHEMBL14760516 | 0.82 | NPSR1 (0.40) | NPSR1MEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130244185-A9 | RADIATION-SENSITIVE RESIN COMPOSITION, METHOD FOR FORMING RESIST PATTERN, ORGANIC ACID AND ACID GENERATING AGENT | JSR CORPORATION (JP) | 2013-09-19 | — | — | US | disclosed |
| US-20130065186-A1 | RADIATION-SENSITIVE RESIN COMPOSITION, METHOD FOR FORMING RESIST PATTERN, ORGANIC ACID AND ACID GENERATING AGENT | JSR CORPORATION (JP) | 2013-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130244185-A9 | RADIATION-SENSITIVE RESIN COMPOSITION, METHOD FOR FORMING RESIST PATTERN, ORGANIC ACID AND ACID GENERATING AGENT | GLRA3, RER1, RXRG | NPSR1 1899/4885EPHX2 195/4885MEN1 3808/4885 |
| US-20130065186-A1 | RADIATION-SENSITIVE RESIN COMPOSITION, METHOD FOR FORMING RESIST PATTERN, ORGANIC ACID AND ACID GENERATING AGENT | GLRA3, RER1, FPR3 | NPSR1 1960/4885EPHX2 171/4885MEN1 3872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.